Mangoceuticals, Inc. Common Stock (MGRX)

Typically moves ±17.67% on earnings
EARNINGS ANALYTICS
search

Mangoceuticals, Inc. Common Stock (MGRX) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +34.59% (Oct 19, 2023) and its biggest decline was -0.75% (Aug 15, 2024).

Earnings reactions

How MGRX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±17.67%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 15, 2024 ☀ PRE -0.75% open_in_new
Oct 19, 2023 ☀ PRE +34.59% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±17.67%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 5 →
5
Funds holding
$23903
Total value held
Buying
3 added · 0 reduced
Northern Trust Corp
$13532 Held
Stonex Group Inc.
$5776 NEW BUY
Goldman Sachs Group Inc
$4234 NEW BUY
Morgan Stanley
$360 Held
Citigroup Inc
$1 NEW BUY

Frequently asked about MGRX earnings

How much does MGRX stock move after earnings? expand_more

Over 2 reports, MGRX has moved an average of ±17.67% the session after earnings, closing higher 50.0% of the time.

What was MGRX's biggest post-earnings move? expand_more

MGRX's largest post-earnings gain on record was +34.59% on Oct 19, 2023, and its largest decline was -0.75% on Aug 15, 2024.

Where can I find Mangoceuticals, Inc. Common Stock's SEC filings? expand_more

All of Mangoceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.